Channel strategy decisions are coming under fresh scrutiny, with industry executives debating where manufacturers should begin when reassessing how they reach patients and customers.
The question sits at the heart of a growing conversation about whether traditional distribution models are still fit for purpose in a rapidly shifting healthcare landscape.
A new instalment in the Executive Conversations series puts three senior voices in the room to wrestle with that challenge directly and practically.
Cheryl Allen, Nick Calla, and Rena Goins take part in the discussion, which forms Episode 2, Part 3 of the ongoing series, published on November 19th, 2026.
The trio address a deceptively simple but strategically loaded question: where exactly should manufacturers start when they evaluate their channel approach?
Getting the starting point wrong, executives increasingly argue, can lead organisations to optimise around the wrong priorities, building distribution infrastructure that serves internal logic rather than end users.
Patient advocacy has emerged as one of the more significant forces reshaping how channel design is being considered, with advocates pushing for greater say in how products reach the people who need them.
The inclusion of patient perspectives in what has traditionally been a purely commercial conversation represents a meaningful shift in how manufacturers are being asked to think about reach and access.
Allen, Calla, and Goins bring different vantage points to the discussion, making the conversation a rare opportunity to hear competing priorities stress-tested against one another in real time.
The Executive Conversations format is designed to surface the kind of strategic tension that rarely appears in formal presentations, drawing out disagreement and nuance rather than consensus talking points.
For manufacturers currently weighing channel decisions, the debate raises uncomfortable questions about whether existing frameworks account sufficiently for patient-centred considerations.
The episode adds to a body of work in the series that treats channel strategy not as a logistics problem but as a question with direct implications for who ultimately benefits from a product reaching the market.

